BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25480927)

  • 1. Monoclonal antibodies specific for the capsid protein of chikungunya virus suitable for multiple applications.
    Goh LYH; Hobson-Peters J; Prow NA; Gardner J; Bielefeldt-Ohmann H; Suhrbier A; Hall RA
    J Gen Virol; 2015 Mar; 96(Pt 3):507-512. PubMed ID: 25480927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
    Lam S; Nyo M; Phuektes P; Yew CW; Tan YJ; Chu JJ
    MAbs; 2015; 7(6):1178-94. PubMed ID: 26305993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Chikungunya Virus Capsid Protein Contains Linear B Cell Epitopes in the N- and C-Terminal Regions that are Dependent on an Intact C-Terminus for Antibody Recognition.
    Goh LY; Hobson-Peters J; Prow NA; Baker K; Piyasena TB; Taylor CT; Rana A; Hastie ML; Gorman JJ; Hall RA
    Viruses; 2015 Jun; 7(6):2943-64. PubMed ID: 26061335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
    Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic potential of monoclonal antibodies against the capsid protein of chikungunya virus for detection of recent infection.
    Damle RG; Jayaram N; Kulkarni SM; Nigade K; Khutwad K; Gosavi S; Parashar D
    Arch Virol; 2016 Jun; 161(6):1611-22. PubMed ID: 27016930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design.
    Taylor A; Liu X; Zaid A; Goh LY; Hobson-Peters J; Hall RA; Merits A; Mahalingam S
    mBio; 2017 Feb; 8(1):. PubMed ID: 28223458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Specific CHIKV-E2 Monoclonal Antibody for Chikungunya Diagnosis.
    Kim J; Yang J; Kim YB; Lee HJ; Kim S; Poo H
    Virol Sin; 2019 Oct; 34(5):563-571. PubMed ID: 31214999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of mouse monoclonal antibodies targeting linear epitopes on Chikungunya virus E2 glycoprotein.
    Chua CL; Chan YF; Sam IC
    J Virol Methods; 2014 Jan; 195():126-33. PubMed ID: 24134938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing monoclonal antibodies to the E2 protein of chikungunya virus protects against disease in a mouse model.
    Goh LY; Hobson-Peters J; Prow NA; Gardner J; Bielefeldt-Ohmann H; Pyke AT; Suhrbier A; Hall RA
    Clin Immunol; 2013 Dec; 149(3):487-97. PubMed ID: 24239837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of monoclonal antibody against non-structural protein-2 of Chikungunya virus and its application.
    Chattopadhyay S; Kumar A; Mamidi P; Nayak TK; Das I; Chhatai J; Basantray I; Bramha U; Maiti PK; Singh S; Suryawanshi AR; Chattopadhyay S
    J Virol Methods; 2014 Apr; 199():86-94. PubMed ID: 24462973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious Chikungunya Virus (CHIKV) with a Complete Capsid Deletion: a New Approach for a CHIKV Vaccine.
    Zhang YN; Deng CL; Li JQ; Li N; Zhang QY; Ye HQ; Yuan ZM; Zhang B
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31092567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel antibodies against non-structural proteins nsP1, nsP3 and nsP4 of chikungunya virus: potential use in basic research.
    Kumar S; Mamidi P; Kumar A; Basantray I; Bramha U; Dixit A; Maiti PK; Singh S; Suryawanshi AR; Chattopadhyay S; Chattopadhyay S
    Arch Virol; 2015 Nov; 160(11):2749-61. PubMed ID: 26280524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus.
    Fumagalli MJ; de Souza WM; Espósito DLA; Silva A; Romeiro MF; Martinez EZ; da Fonseca BAL; Figueiredo LTM
    Virol J; 2018 Jul; 15(1):112. PubMed ID: 30041676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning, expression and evaluation of diagnostic potential of recombinant capsid protein based IgM ELISA for chikungunya virus.
    Priya R; Khan M; Rao MK; Parida M
    J Virol Methods; 2014 Jul; 203():15-22. PubMed ID: 24681089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promising application of monoclonal antibody against chikungunya virus E1-antigen across genotypes in immunochromatographic rapid diagnostic tests.
    Suzuki K; Huits R; Phadungsombat J; Tuekprakhon A; Nakayama EE; van den Berg R; Barbé B; Cnops L; Rahim R; Hasan A; Iwamoto H; Leaungwutiwong P; van Esbroeck M; Rahman M; Shioda T
    Virol J; 2020 Jul; 17(1):90. PubMed ID: 32615978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad-spectrum monoclonal antibodies against chikungunya virus structural proteins: Promising candidates for antibody-based rapid diagnostic test development.
    Tuekprakhon A; Puiprom O; Sasaki T; Michiels J; Bartholomeeusen K; Nakayama EE; Meno MK; Phadungsombat J; Huits R; Ariën KK; Luplertlop N; Shioda T; Leaungwutiwong P
    PLoS One; 2018; 13(12):e0208851. PubMed ID: 30557365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal Antibodies as Prophylactic and Therapeutic Agents Against Chikungunya Virus.
    Clayton AM
    J Infect Dis; 2016 Dec; 214(suppl 5):S506-S509. PubMed ID: 27920182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imported cases of Chikungunya virus in Iran.
    Pouriayevali MH; Rezaei F; Jalali T; Baniasadi V; Fazlalipour M; Mostafavi E; Khakifirouz S; Mohammadi T; Fereydooni Z; Tavakoli M; Azad-Manjiri S; Hosseini M; Ghalejoogh M; Gouya MM; Failloux AB; Salehi-Vaziri M
    BMC Infect Dis; 2019 Nov; 19(1):1004. PubMed ID: 31775718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chikungunya Virus Growth and Fluorescent Labeling: Detection of Chikungunya Virus by Immunofluorescence Assay.
    Moi ML; Takasaki T
    Methods Mol Biol; 2016; 1426():143-52. PubMed ID: 27233268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of Chikungunya virus inhibition by monoclonal antibodies.
    Zhou QF; Fox JM; Earnest JT; Ng TS; Kim AS; Fibriansah G; Kostyuchenko VA; Shi J; Shu B; Diamond MS; Lok SM
    Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27637-27645. PubMed ID: 33087569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.